Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Rankning i aktier #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Aktiekurs
$0.000001
Senast synkroniserad: 2023-12-13
Marknadsvärde
$23.51
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Allena Pharmaceuticals, Inc. (ALNAQ)

Kategori

Utdelningsavkastning för Allena Pharmaceuticals, Inc. (ALNAQ)
Utdelningsavkastningen (TTM) för Allena Pharmaceuticals, Inc. (aktiesymbol: ALNAQ) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Allena Pharmaceuticals, Inc. (ALNAQ) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter